Russell Investments Group
HOWL icon

Russell Investments Group’s Werewolf Therapeutics HOWL Stock Holding History

Russell Investments Group’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-86
Closed -$182 – 3740
2024
Q3 		$182 Buy
+86
New +$196 ﹤0.01% 3645
2021
Q4 		– Sell
-125,873
Closed -$2.16M – 3047
2021
Q3 		$2.16M Buy
+125,873
New +$2.15M ﹤0.01% 1790

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Russell Investments Group's HOWL Position: Q4 2024 in Review

Russell Investments Group sold out of Werewolf Therapeutics (HOWL) in Q4 2024, closing a stake of 86 shares — an estimated $182 sold.

Russell Investments Group first reported a position in HOWL in Q3 2021 and held it in 2 quarters. The position peaked at $2.16M in Q3 2021. 73 funds tracked by Wall St. Rank hold HOWL as of Q4 2024.

  • Russell Investments Group reported no remaining Werewolf Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Russell Investments Group sold 86 Werewolf Therapeutics shares in Q4 2024, an estimated $182.
  • Russell Investments Group first reported a position in Werewolf Therapeutics in Q3 2021 and held it in 2 quarters.
  • Russell Investments Group's Werewolf Therapeutics position peaked at $2.16M in Q3 2021.
  • 73 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q4 2024.

Based on Russell Investments Group's 13F filing for Q4 2024, filed 13 Feb 2025.